Home
AbbVie ABBV paid Tarplin, Downs & Young $60K for lobbying in Q1 2025 · Health Issues, Medicare and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q1 2025
- Stock
- AbbVie ABBV
- Client
- Abbvie
- Reported
- 25/04/20
Up 0.0% from last quarter
What else happened in AbbVie around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Abbvie's other lobbying reports
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$50K
$50K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$60K
$60K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$1.2M
$1.2M
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$60K
$60K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$30K
$30K
Reported 07/20
for Q2